Cytochrome P450 and steroid 21-hydroxylation in microsomes from beef adrenal cortex

Cytochrome P450 in beef adrenal cortex microsomal preparations reacted with progesterone and with 17-hydroxyprogesterone at pH 7.4 to produce Type I spectral changes. The magnitude of the spectral shift produced by addition of progesterone or 17-hydroxyprogesterone was related to the concentration of cytochrome P450 (over P450 concentration range of 0.1 to 0.3 μM). Prior saturation of cytochrome P450 with 17-hydroxyprogesterone prevented further spectral shift with the addition of progesterone. On the other hand, saturation of cytochrome P450 with progesterone decreases the expected shift with 17-hydroxyprogesterone by more than 50% but did not prevent the shift. The difference spectra were diminished by more than 50% at pH 9.0.The addition of NADPH resulted in loss of the spectral shifts and production of 21-hydroxylated products, predominantly DOC and 11-deoxycortisol. These reactions were not inhibited by their specific products. The rate of 21-hydroxylation was linearly related to microsomal protein (and microsomal P450) concentration. The 21-hydroxylation of progesterone was competitively inhibited by 17-hydroxyprogesterone; inhibition of the 21-hydroxylation of 17-hydroxyprogesterone by progesterone was not demonstrated.     

Sources of reducing equivalents for the microsomal steroid 21-hydroxylation in isolated rat adrenal cells.

21-Hydroxylation of 11β-hydroxyprogesterone in the intact adrenal cells was stimulated by both glucose and pyruvate. Arsenite inhibited the basal as well as the pyruvatesupported reaction and also prevented the entry of pyruvate carbon into the Krebs cycle. Glucose-supported 21-hydroxylation was not inhibited by arsenite. It is proposed that NADPH for the microsomal 21-hydroxylation is derived by at least two mechanisms: (1) metabolism of glucose via the pentose shunt and (2) a mechanism involving transfer of reducing equivalents from the mitochondria into the cytosol. The latter would involve the transfer of some Krebs cycle intermediate (or intermediates) from the mitochondria to the cytosol followed by its eventual metabolism in the cytosol via an NADPH-linked dehydrogenase. This mechanism may assume importance when the cell has a limited supply of glucose.     

Spironolactone and cytochrome P-450: impairment of steroid 21-hydroxylation in the adrenal cortex.

The effect of spironolactone administration on the activities of adrenal 21-hydroxylases was examined in male cortisol- and corticosterone-producing animals. Decreases in the activities of the 21-hydroxylases after spironolactone treatment occur only in those animals that predominantly produce cortisol rather than corticosterone and that have a high activity of adrenal steroid 17α-hydroxylase. The administration of spironolactone to cortisol-producing animals, namely, the guinea pig and the dog, caused a 50–75% loss in the activities of adrenal 21-hydroxylases with a concomitant decrease in the content of microsomal cytochrome P-450 and microsomal heme and in the activity of microsomal 17α-hydroxylase. Spironolactone treatment was also found to decrease the content of adrenal mitochondrial cytochrome P-450 in male guinea pigs but not male dogs. In contrast to its effect in cortisol-producing animals, the administration of spironolactone caused an increase in the activities of the microsomal 21-hydroxylases in the adrenals of corticosterone-producing animals such as the rat and the rabbit.     

Structural analysis of cloned cDNA for mRNA of microsomal cytochrome P-450(C21) which catalyzes steroid 21-hydroxylation in bovine adrenal cortex

We have isolated cDNA clones of the mRNA for cytochrome P-450 that catalyzes the steroid C-21 hydroxylation (P-450(C21)), which specifically catalyzes 21-hydroxylation of steroids in the microsomes of bovine adrenal cortex by using synthetic oligonucleotides as probes. Sequence determination of the cloned cDNA showed that it contains 2157 nucleotides and a poly(A) chain and that a single open reading frame of 1488 nucleotides codes for a polypeptide of 496 amino acids with a molecular weight of 56,113. The deduced amino acid composition is in agreement with that determined by direct amino acid analysis of purified P-450(C21) and the predicted primary structure contained amino acid sequences of N-terminal region and two internal tryptic fragments of the protein so far analyzed. Comparing the amino acid sequence with those of other forms of P-450 reveals that a conserved amino acid sequence containing a putative heme-binding cysteine is present in the equivalent position, proximate to the COOH terminus of the molecules and that P-450(C21) is phylogenically situated in an intermediate position between steroidogenic mitochondrial cytochrome P-450 which catalyzes the side-chain cleavage of cholesterol (P-450(SCC)) and drug-metabolizing microsomal P-450s. However, the amino acid sequence of P-450(C21) is much closer to that of drug-metabolizing P-450s than to that of P-450(SCC).     

Maintenance of steroid 11-hydroxylation activity in immobilized Cunninghamella elegans protoplasts

World Journal of Microbiology and Biotechnology -     

Renal 21-hydroxylation of 19-hydroxy-progesterone to 19-hydroxy-deoxycorticosterone

19-Nor-deoxycorticosterone (19-nor-DOC) is a mineralocorticoid present in both rat and human urine, and it is elevated in some forms of experimental and human hypertension. Although the exact steps in the biosynthesis of 19-nor-DOC are uncertain, it is probably produced from a 19-oxygenated derivative of DOC, which undergoes 19-desmolation in the kidney. Since DOC biosynthesis is partly due to renal 21-hydroxylation of progesterone (Prog), we sought to determine whether a parallel pathway could exist for the biosynthesis of 19-hydroxy-DOC, a precursor to 19-nor-DOC. In order to test this hypothesis, authentic 19-hydroxy-progesterone was incubated with homogenized renal tissues from either rat or human sources. Formation of 19-hydroxy-DOC was found to be the major metabolite in both rat and human incubations, as demonstrated by an HPLC retention time identical to authentic 19-hydroxy-DOC. 19-Hydroxy-DOC formation was further verified by GC/MS analysis with highly sensitive selected ion recording. Since it has been demonstrated that the placenta can convert progesterone to 19-hydroxy-progesterone, the renal 21-hydroxylation of 19-hydroxy-progesterone to 19-hydroxy-DOC could be an alternate pathway of 19-nor-DOC production especially during pregnancy.     

Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia

21-Hydroxylase deficiency which causes congenital adrenal hyperplasia is one of the most common defects of adrenal steroidogenesis. There are two 21-hydroxylase genes in man, A and B, and these have been mapped to the HLA class III region. Only the 21-hydroxylase B gene is thought to be active. To understand the molecular basis of congenital adrenal hyperplasia in a patient with the salt-wasting form of the disease, we cloned and characterized his single 21-hydroxylase B gene. The nucleotide sequence of this gene and a 21-hydroxylase B gene from a normal individual have been determined. Comparison of the two sequences has revealed 11 nucleotide alterations, of which two are in the 5' flanking region, four are in introns, one is in the 3' untranslated region and four are in exons. Two of the differences in exons cause codon changes, with Ser-269 and Asn-494 in the normal 21-hydroxylase B gene being converted to Thr and Ser, respectively. These amino acid substitutions may give an insight into those residues necessary for 21-hydroxylase enzymatic activity. We have also confirmed that the 21-hydroxylase A gene is a pseudogene due to three deleterious mutations in the exons. In addition, comparison of the 21-hydroxylase B gene sequence with other published sequences indicates that this microsomal cytochrome P-450 may be polymorphic.     

Measuring the structural impact of mutations on cytochrome P450 21A2, the major steroid 21-hydroxylase related to congenital adrenal hyperplasia

Abstract

Congenital adrenal hyperplasia is an inherited autosomal recessive disorder related to deficient cortisol synthesis. The deficiency of steroid 21-hydroxylase (cytochrome P450 21A2), an enzyme involved in cortisol synthesis, is responsible for ～95% of cases of congenital adrenal hyperplasia. This metabolic disease exhibits three clinical forms: salt-wasting, simple virilizing, and non-classical form, which are divided according to the degree of severity. In the present study, structural and mutational analyses were performed in order to identify the structural impact of mutations on cytochrome P450 21A2 and correlate them with patient clinical severity. The following mutations were selected: arginine-356 to tryptophan (R356W), proline-30 to leucine (P30L), isoleucine-172 to asparagine (I172N), valine-281 to leucine (V281L), and the null mutation glutamine-318 (Q318X). Our computational approach mapped the location of residues on P450 and identified their implications on enzyme electrostatic potential mapping to progesterone and heme binding pockets. Using molecular dynamics simulations, we analyzed the structural stability of ligand binding and protein structure, as well as possible conformational changes at the catalytic pocket that leads to impairment of enzymatic activity. Our study sheds light on the impact structural mutations have over steroid 21-hydroxylase structure-function in the cell.

Communicated by Ramaswamy H. Sarma     

Further studies on corticosteroidogenesis VI. Pyruvate and malate supported steroid 11β-hydroxylation in rat adrenal gland mitochondria

Pyruvate and pyruvate plus ATP have been shown to support 11β-hydroxylation of 11-deoxycorticosterone into corticosterone in incubated rat adrenal gland mitochondria. Corticosterone production with pyruvate plus ATP was not as great as with malate plus P_i, malate plus ATP or malate plus pyruvate. Respiratory chain inhibitors, trans-aconitate, oxaloacetate, arsenite and the uncoupler 2,4-dinitrophenol, inhibited corticosterone formation. On the other hand, cysteine sulfinate and pyruvate, which led to the removal of excess metabolic oxaloacetate formed from malate oxidation, increased rat adrenal mitochondrial O₂ consumption as well as corticosterone production from 11-deoxycorticosterone. P_i and ATP also appeared to act in the same way in that these agents brought about a greater conversion rate of oxaloacetate into pyruvate. Pyruvate, resulting from the oxidation of malate, accumulated in the incubation system only when arsenite was added. Arsenite additions to malate and isocitrate inhibited the conversion of 11-deoxycorticosterone into corticosterone except when the 11β-hydroxylation of 11-deoxycorticosterone was supported with exogenous NADPH in Ca²⁺-swollen mitochondria. These results as well as the observations that NAD-linked malate dehydrogenase ( -malate: NAD⁺ oxidoreductase (decarboxylating), EC 1.1.1.39) is at least 10 times as active as the NADP-linked enzyme ( -malate: NADP⁺ oxidoreductase (decarboxylating), EC 1.1.1.39) in sonicated rat adrenal gland mitochondria, led to the conclusion that under our incubation conditions malate was mainly oxidized via the NAD-linked malate dehydrogenase. The fact that in malate incubations pyruvate did not accumulate because of its further metabolism in rat adrenal gland mitochondria, does not support the possibility that these mitochondria are the source of pyruvate for a “malate shuttle” originally thought to occur in rat adrenal gland⁷. This shuttle would have depended on the formation of pyruvate from malate in rat adrenal gland mitochondria followed by extrusion of the pyruvate formed intramitochondrially into the cytoplasm of the cell.